Mechanism(s) of CD8 T cell-mediated Chlamydia-induced reproductive pathology
CD8 T 细胞介导的衣原体诱导的生殖病理机制
基本信息
- 批准号:9099463
- 负责人:
- 金额:$ 45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigensBiological MarkersBiological Response ModifiersBiomedical ResearchBlindnessCD4 Positive T LymphocytesCD8B1 geneCardiovascular DiseasesCellsChlamydiaChlamydia InfectionsChlamydophila pneumoniaeClinical TrialsDevelopmentEctopic PregnancyEducational process of instructingEnsureFemaleFrequenciesFunding MechanismsGenital systemGoalsGrantHumanImmune responseImmunizationInfertilityInstitutionInterferonsInterleukin-17LaboratoriesLeadLearningLungMediatingMediator of activation proteinModelingMusNeutrophil InfiltrationPathogenesisPathologyPathway interactionsPelvic Inflammatory DiseaseProductionRegimenReiter DiseaseResearchRoleScientific Advances and AccomplishmentsSourceStagingStreamStructureStudentsT cell responseT-LymphocyteTNF geneTumor Necrosis Factor ReceptorUniversitiesVaccinationVaccinesWomanWorkbasecareer developmentclinically relevantclinically significantmouse modelneutrophilpathogenpreclinical trialpreventpublic health relevancereproductivereproductive tractresponsevaccine development
项目摘要
DESCRIPTION (provided by applicant): Chlamydial infections underlie the development of several clinically significant pathologies including blindness, female reproductive tract pathology cardiovascular diseases, and reactive arthritis. The long term goal of our research is to understand the mechanisms of chlamydial pathogenesis and prevent them. A vaccine is against Chlamydia is thought to be the ideal solution to prevent reproductive pathologies in the female upper genital tract (UGT). Since the host immune response or a subset is also responsible for these pathologies, the question arises: "How do we ensure that a vaccine does not inadvertently induce the pathologies that it was intended to prevent?" To this end, a deep understanding of chlamydial immunopathogenesis is needed, whereas it is currently incompletely understood. We have recently demonstrated various lines of evidence that antigen-specific, TNF-α producing, TNF receptor 2 expressing CD8+ T cells induce upper genital tract pathology following chlamydial infections. In this proposal, we will address the hypothesis that "Antigen- specific CD8+ T cells are a key regulator of pathogenic responses following chlamydial infections" and evaluate the modulation of such responses by protective vaccination regimens. The significance of addressing this hypothesis is as follows: A variety of immunological mediators have been shown to mediate chlamydial pathogenesis and our work demonstrates Chlamydia-specific CD8+ T cells as an additional mediator. Based on this, two important inferences can be made: (A) Various pathogenic mediators appear to function in a serial cascade since pathology can be significantly reduced by deleting one component, for example Ag-specific CD8+ T cells. This suggests that avoiding the elicitation of a key component in this pathway may be sufficient to reduce pathology, and (B) CD8+ T cells mediate pathology in an antigen (Ag)-specific fashion. Thus, the avoiding the elicitation of Ag-specific pathogenic CD8+ T cells would become a superior avoidance strategy when compared to innate immune mediators during preclinical and clinical trials of chlamydial vaccines. We will address our hypothesis with the following subaims: Aim 1. Determine whether Chlamydia-specific CD8+ T-cells engage neutrophils for pathogenesis. Aim 2. Determine whether protective vaccine regimens significantly reduce pathology by circumventing the pathogenic CD8+ T-cell response.
描述(由申请方提供):衣原体感染是几种具有临床意义的病理学发展的基础,包括失明、女性生殖道病理学心血管疾病和反应性关节炎。我们研究的长期目标是了解衣原体的发病机制和预防它们。针对衣原体的疫苗被认为是预防女性上生殖道(UGT)生殖病理的理想解决方案。由于宿主免疫应答或亚群也是这些病理的原因,因此出现了以下问题:“我们如何确保疫苗不会无意中诱导其旨在预防的病理?“为此,需要深入了解衣原体免疫发病机制,而目前还不完全了解。我们最近已经证明了抗原特异性的、产生TNF-α的、表达TNF受体2的CD 8 + T细胞在衣原体感染后诱导上生殖道病理的各种证据。在本提案中,我们将解决“抗原特异性CD 8 + T细胞是衣原体感染后致病性应答的关键调节因子”的假设,并评估保护性疫苗接种方案对此类应答的调节。解决这一假设的意义如下:各种免疫介质已被证明介导衣原体的发病机制,我们的工作表明衣原体特异性CD 8 + T细胞作为一个额外的介质。基于此,可以做出两个重要的推论:(A)各种致病介质似乎以串联级联起作用,因为病理可以通过删除一种组分(例如Ag特异性CD 8 + T细胞)而显著减少。这表明,避免引发该途径中的关键组分可能足以减少病理,并且(B)CD 8 + T细胞以抗原(Ag)特异性方式介导病理。因此,在衣原体疫苗的临床前和临床试验期间,与先天免疫介质相比,避免Ag特异性致病性CD 8 + T细胞的激发将成为上级避免策略。我们将通过以下子目标来解决我们的假设:目标1。确定衣原体特异性CD 8 + T细胞是否参与中性粒细胞的发病机制。目标二。确定保护性疫苗方案是否通过规避致病性CD 8 + T细胞应答来显著减少病理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ashlesh Krishna Murthy其他文献
Ashlesh Krishna Murthy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ashlesh Krishna Murthy', 18)}}的其他基金
Mechanism(s) of CD8 T cell-mediated Chlamydia-induced reproductive pathology
CD8 T 细胞介导的衣原体诱导的生殖病理机制
- 批准号:
8575045 - 财政年份:2013
- 资助金额:
$ 45万 - 项目类别:
Role of CD8+ T cells in Reproductive Sequelae Induced by Chlamydia Infection
CD8 T 细胞在衣原体感染引起的生殖后遗症中的作用
- 批准号:
8402421 - 财政年份:2010
- 资助金额:
$ 45万 - 项目类别:
Role of CD8+ T cells in Reproductive Sequelae Induced by Chlamydia Infection
CD8 T 细胞在衣原体感染引起的生殖后遗症中的作用
- 批准号:
7874276 - 财政年份:2010
- 资助金额:
$ 45万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 45万 - 项目类别:
Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别:
Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别:
Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别: